Northwestern University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).
Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.
Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.
Top-decile sponsor footprint
Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,209 total, page 13 of 25
Patient Comfort During Dermatologic Procedures
NCT02816996
A Culturally Targeted Transplant Program
NCT03276390
The PROMISE Study: Duavee in Women With DCIS
NCT02694809
Cocoa to Improve Walking Performance in Peripheral Artery Disease
NCT02876887
Does Radiofrequency Ablation of the Articular Nerves of the Knee Prior to Total Knee Replacement Improve Pain Outcomes
NCT02746874
Presence of a Companion During Performance of Neuraxial Labor Analgesia
NCT02982213
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
NCT03041038
Myoelectric Upper Limb Orthosis Use by Persons With TBI and Stroke
NCT03215771
Sacral Neuromodulation and the Microbiome
NCT02833402
Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT02901899
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma
NCT02794883
Understanding Perspectives of Frequently-Admitted Hospital Patients
NCT03097640
IV Tranexamic Acid Prior to Hysterectomy
NCT02911831
Mechanical Support Measures of Adjustment and QOL
NCT03044535
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments
NCT03051347
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
NCT03002363
Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis
NCT02774681
Prenatal Alcohol Biomarker Study in Uruguay
NCT02600624
Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education
NCT02871752
Comparing the Effectiveness of Clinicians and Paraprofessionals to Reduce Disparities in Perinatal Depression
NCT02979444
Online Positive Emotion Skills Intervention for Symptoms of Depression
NCT02861755
Health Effects of Mentoring
NCT02900638
Optimizing Medication Management for Mothers With Depression
NCT02519790
Enhanced Recovery After Surgery Gynecology Oncology
NCT02864277
Barriers to Care and QOL for CCCA Patients
NCT03044782
Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer
NCT02837029
IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression
NCT02801877
Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
NCT03358355
Walking Green: The Effects of Walking in Forested and Urban Areas
NCT03950661
Patient-Centered Weight Loss Program for Knee Replacement Patients
NCT02728661
Teaching Skin Self -Examination to Melanoma Patients and Their Skin Check Partners
NCT02854657
Association of Donor Age With Recipient Outcomes in Kidney Transplant
NCT02514733
Functional Performance Evaluation of NU-FlexSIV Socket
NCT02678247
The "Light for the Brain" Study
NCT02677987
The Northwestern University Two-Generation Study of Parent and Child Human Capital Advancement
NCT02743039
Vulvar Mucosal Specialty Clinic Chart Review
NCT02881229
Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
NCT02720484
Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation
NCT02736227
Smartphone Application to Detect Skin Lesions
NCT02740257
A Smart, "Always -On" Health Monitoring System
NCT02865070
Pharmacokinetics of Quetiapine Across Pregnancy and Postpartum
NCT02978534
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
NCT02370693
Degenerative Mitral Regurgitation in Intermediate Risk Patients
NCT02604745
Vulvar Scarring Grading Scale for Lichen Sclerosus
NCT02880904
Vaginal Electrical Stimulation for Postpartum Neuromuscular Recovery
NCT02701413
Healthy Combine Study
NCT03136705
The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence
NCT02678377
Designing a Programming Language for Patient-Oriented Prescriptions
NCT02820168
Bump on the Ball: Impact of a Prenatal Exercise & Education Program on Birth Outcomes & Maternal Quality of Life
NCT02334397
Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate
NCT03853902
What is open in the Northwestern University pipeline
187 recruiting of 1,209 indexed (15% open); 767 completed (63%).
Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).
Top condition: Depression (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Northwestern University: open-pipeline peers nationwide
Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,209 trials (± recruiting share)
- Emory University · 1,208 trials · 17% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Brigham and Women's Hospital · 15% recruiting · 937 trials
- Incyte Corporation · 15% recruiting · 239 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Northwestern University page
1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.
- 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.